JPMorgan raised the firm’s price target on Mettler-Toledo (MTD) to $1,285 from $1,200 and keeps a Neutral rating on the shares as part of a Q3 preview for the life science tools group. The firm sees tools companies taking a more conservative stance on 2026 pending more evidence of order improvement. JPMorgan lowered 2026 numbers for several tools companies into the quarter.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTD: